Timely identification of actionable targets in acute myeloid leukaemia

We presented a poster written in collaboration between the University Hospital Carl Gustav Carus, Dr Anke Weber, and Dr Matthias Preussler titled "A new multiplex PCR tool enabled timely identification of actionable targets for molecular-guided therapy in patients with acute myeloid leukemia" during this year's EHA2023 congress in Frankfurt.

The study aimed to develop multiplex PCR assays that simultaneously detected gene fusions and mutations relevant to the ELN guideline, resulting in faster results compared to NGS or conventional Sanger sequencing.

Discover how our proprietary MODAPLEX platform successfully combines the analysis of AML-relevant gene mutations, duplications, and translocations using two multiplex PCR assays in parallel. Click the link below to learn more!

Contact us to learn more about our innovative MODAPLEX platform and how we can support you in consolidating assays into one customized multiplex.  

E-POSTER: https://modaplex.biotype.de/wp-content/uploads/2023/06/EHA2023-Poster-MODAPLEX-AMLplus.pdf